Applications of 1-[Cyano-(P-Methoxyphenyl)Methyl]Cyclohexanol in Industrial Manufacturing

As a producer of high-purity 1-[Cyano-(P-Methoxyphenyl)Methyl]Cyclohexanol, we supply the pharmaceutical, agrochemical, specialty chemicals, research intermediates, and advanced materials sectors. Each application leverages the specific chemical properties and structural features of this raw material for manufacturing downstream products that meet defined quality and compliance requirements.

1. Pharmaceutical Intermediate Synthesis

Pharmaceutical manufacturers utilize this compound as a key intermediate in the synthesis of central nervous system (CNS) active agents, specifically those in the serotonin and norepinephrine reuptake inhibitor (SNRI) class. Its protected phenolic group and cyano functionality serve as essential starting points for multi-step transformations within GMP-regulated facilities. In process development, formulators select this intermediate due to its reactivity profile and stability under reaction conditions, which minimizes impurity levels and facilitates downstream purification. Close monitoring of residual solvents and isomer content, as required by regulatory submissions, ensures final APIs adhere to strict therapeutic standards.

Industry compliance standards

• ICH Q7 GMP Guidelines for Active Pharmaceutical Ingredients
• United States Pharmacopeia (USP, General Chapter <795> Nonsterile Compounding)
• European Pharmacopoeia (Ph. Eur.) standards for related intermediates
• FDA 21 CFR Part 211—Finished Pharmaceuticals

Typical usage ratio

• Applied at 0.8 to 1.2 molar equivalents depending on the final API molecular structure
• Adjustments for solvent systems and impurity control based on in-process QC data

Downstream process integration

• Charged at the condensation or alkylation reaction stage for key API backbone construction
• Subjected to nitrile reduction or oxidative cleavage in subsequent synthetic steps
• Intermediates enter final purification through crystallization or preparatory chromatography

Final product types

• CNS active pharmaceutical ingredients such as antidepressants and anxiolytics
• Regulatory-submitted bulk and formulated drug products
• Validated clinical research compounds for early phase trials
• High-purity reference standards for analytical quality control

2. Agrochemical Active Ingredient Manufacturing

This raw material is implemented by agrochemical formulators for the synthesis of specialty herbicide and pesticide intermediates featuring cyclohexanol or aromatic cyano scaffolds. Its electron-donating and withdrawing group combination allows for regioselective modifications under catalytic hydrogenation or halogenation. Manufacturers use controlled batch processes to ensure traceability and repeatability, and maintain active substance purity for future registration dossiers. Regulatory compliance requires routine impurity profiling and stability testing during scale-up.

Industry compliance standards

• FAO/WHO Specifications for Agricultural Pesticide Ingredients
• EU Regulation (EC) No 1107/2009—Authorization of Plant Protection Products
• ISO 17025-certified QC laboratories for analytical release
• REACH Annex II Safety Data Sheet (SDS) requirements

Typical usage ratio

• Used at 10%–20% by weight relative to total intermediate mass in multistep synthesis
• Tailored loading based on targeted herbicide class (pre-emergent or post-emergent)

Downstream process integration

• Integrated at the selective reduction or cross-coupling step for ring-functionalized active compounds
• Intensive in-process HPLC and GC-MS monitoring to ensure conformance with maximum impurity thresholds
• Final actives isolated through solvent extraction and rotary evaporation

Final product types

• Herbicide AI variants for systemic and contact use
• Ready-to-formulate pesticidal concentrates and dispersible granules
• Standardized actives for field efficacy trials
• Analytical reference compounds for residue analysis

3. Specialty Polymer Modifier Production

High-performance materials producers incorporate this molecule for the modification of thermoset resins and engineering plastics. Its cyano and methoxyphenyl groups enhance crosslink density and introduce polarity, yielding custom polymers with increased adhesion, controlled flexibility, and improved chemical resistance. Process engineers streamline dosing and blending into pre-polymer melts, monitoring viscosity and curing kinetics. Consistency in functional group content post-integration impacts final part performance for demanding electrical and automotive components.

Industry compliance standards

• RoHS Directive 2011/65/EU for restricted substance levels
• ISO 9001:2015 Certified Quality Management Systems
• UL 94 Flammability Standards for Plastics
• ANSI/ASTM D256 for polymer impact strength

Typical usage ratio

• Introduced at 0.5–3% by weight relative to monomer or pre-polymer feedstock
• Adjusted based on molecular weight distribution and targeted end-use performance

Downstream process integration

• Employed during in situ polymerization or as a post-polymer blending additive
• Dispersion managed by monitored shear blending, followed by thermal curing
• Material validated via FTIR spectroscopy for completion of chemical incorporation

Final product types

• Modified epoxy laminates for printed circuit boards
• Adhesive-grade polyurethanes for automotive assembly
• Engineered plastic masterbatches with enhanced property profiles
• Insulation materials for electrical applications

4. Fine Chemical Synthesis for Research and Development

Custom synthesis and contract development organizations deploy this intermediate for the production of niche compounds and analytical standards needed in medicinal and material science R&D. The unique reactivity of both the cyano and protected phenolic moieties makes it suitable for SAR studies, enabling rapid analogue generation via reduction, hydrolysis, or alkylation. Rigorous batch documentation and impurity tracking are maintained for reproducibility in research settings, while certified analytical data supports material traceability in GLP and ISO-compliant laboratories.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP)
• ISO 17034 for Certified Reference Materials
• ASTM E2879–13 for purity assessment by quantitative NMR
• Institutional review board protocols for laboratory chemical safety

Typical usage ratio

• Dosed in the range of 50–200 mg for initial library synthesis
• Higher quantities, up to 5–25 g, depending on scale and compound library size

Downstream process integration

• Used as a limit or core structure for parallel synthesis and combinatorial chemistry
• Reacts in stepwise functional group transformations with monitoring by LC-MS or NMR
• Subsequent products isolated by flash chromatography or preparative HPLC for characterization

Final product types

• Reference standards for HPLC, GC, and MS calibration
• Lead small molecules for medicinal chemistry SAR assays
• Labeled compounds for mechanistic studies
• Analytical control samples for regulatory method validation